1 treatment in CB should be withdrawn
2 is used for chronic constipation
3 may cause flatulence
A 1, 2, 3
B 1, 2 only
C 2, 3 only
D 1 only
E 3 only
Coming together is a beginning. Keeping together is progress. Working together is success. – Henry Ford
Happiness is the real deal
The last chapter of the book, ‘‘The 25 Unbreakable Laws of Sales’’, talks about happiness. Life’s real purpose is to be happy. Everyone wants happiness. The businessman wants to be happy. The buyer and the seller want to be happy. The lecturer and his students want to be happy. Shareholders of every company want a good business environment in order to be happy.

A responsible government works hard to satisfy citizens so that all the stakeholders will be happy. Happiness is the real deal. I am yet to see someone who sets out to bargain for himself the things that will lead to unhappiness, except in an abnormal situation.
Purpose defines direction
Everyone gathers for a purpose. The salesman has a purpose for working in the first place. He wants to take care of his personal and professional needs; maybe work in a competitive environment that will help him build a successful career in order to meet up with his aspirations.
The company has set goals. The company wants to attain its vision and mission. This is the reason organisations gather the best workforce to help them achieve these goals. The customer’s dream is to be happy. He wants to do business with the company that will guarantee peace of mind. He also wants to get the best deal whenever he buys from the company. The customer wants to buy the best product at the best possible offer from the company that gives him the best deal. Everyone has a defined purpose and these purposes give direction in business and in personal life.
Accomplishment begets happiness
Humans are rational and emotional beings. Folks act for a reason. Individuals seek to protect themselves wherever they find themselves. Every man is looking for the best deal that gives a sense of security.
Abraham Maslow’s 1943 Theory of Human Motivation (Hierarchy of Needs) enumerates what motivates a man at different levels of his life and status. Maslow enumerated a five-stage model:
First stage: Biological and physiological needs. These are basic life needs – air, food, clothing and shelter. They are needs for human survival. They are thought to be the most important. They should be met first before any other.
Second stage: Safety needs. They include protection (personal and financial security), health and well-being, order, law, etc.
Third stage: Belongingness and love needs. These are needs for interpersonal relationship. They are: family, affection and relationship.
Fourth stage: Esteem needs. These are needs to feel respected. They includes the need to have self-esteem and self-respect. They are: achievement, status, responsibility, competence, self-confidence, independence and reputation.
Fifth stage: Self-actualisation. This refers to a person’s full potential and the actualisation of that potential. It comprises personal growth and fulfillment.
Maslow believes that when a lower need is satisfied, the next higher stage becomes the new need. Conversely, if the things that satisfy the lower needs are swept away, we are no longer concerned about the maintenance of our higher needs.
This theory is ideal for the thoughts I want to explore here. Everyone has a need to satisfy as I explained earlier. The company has a need. Salesmen have their needs too, same with the customer. The coming together of the stakeholders in any business is to ensure that various needs are attended to.
Successful companies perceive their workforce and customers as assets that are needed if they must get to their destinations. Success in this context is a collective responsibility. The salesman contributes to the success of the company; the business cannot grow without customers and efforts of the salesman. The company also has it as a duty to ensure that all the stakeholders are delighted. This is how everyone becomes happy.
Create an ambience of happiness
No matter the side of the divide you belong, your duty is to ensure that you make other parties happy. Create a happy environment wherever you find yourself. Make this a way of life. Happiness is infectious. Ensure that you carry the aura of happiness everywhere you go. Happiness attracts goodness. People flock around happy people. The happier you are, the more you attract good things around you. Successful people create a happy environment.
Please get the books by George O. Emetuche: The 25 Unbreakable Laws of Sales, The Selling Champion, The Art of Sales, The 11 Irrefutable Principles of Success and Everything is Possible, from: Pharmanews Vendors, Laterna Bookshop, Oko Awo Street, Victoria Island, Unilag Bookshop, Jumia, Vog & Word, Osata Supermarket, Opebi, Ikeja, CSS Bookshop, Broad Street, Lagos, Victory Drugs, Festac, Terra Kulture Bookshop, Tiamu Salvage Crescent, Victoria Island, Bible Wonderland, Alaka, Surulere, Glendora Bookshop, Ikeja Shopping Mall, CIBN Bookshop, Banker’s House, Adeola Hopewell, Victoria Island, Jed Mega Stores, De Palms, Lekki, Hub Mart Outlets, etc.
A pharmacist is a healthcare professional licensed to mix, compound, dispense and sell medications to patients. Pharmacists also perform in the capacity to provide patient care by counselling them and providing information on their medications to ensure they use them safely and effectively.
Though the roles of a pharmacist are not limited to the above, it is most essential is to help patients understand everything related to their drugs, as well as improving therapeutic outcome.

Life-saving interventions are carried out by pharmacists in hospital and community practice on a daily basis to ensure better therapeutic outcome for patients. Some include:
* interpreting prescriptions for proper use of medicine,
* providing advice on storage, interactions with other drugs, food or even lifestyle,
* carrying out extemporaneous preparations of medicines especially for children
* recommending lifestyle changes to help improve management of chronic conditions
* providing advice on how to improve compliance to medicines, for example suggesting pill boxes to those with long term illnesses or advice on swallowing techniques with those who find it difficult to comply as a result of swallowing difficulties.
Profile and professionalism
A licensed pharmacist must be smart, well groomed and polite, ready to serve his or her patients with optimum knowledge on all drug related conditions. They must carry out the basic WWHAMA questioning acronym to ensure a holistic counselling session. They must inquire Who is taking the drug, What symptoms are being experienced, How long have the symptoms existed, Actions taken from the inception of the symptoms, Medications taken thus far and Allergies the patients have. This helps chart the course for proper advice to ensure therapeutic effectiveness.
Other basic services expected of a pharmacist include proper labelling of medicines to ensure the issue of overdose is averted. Other issues, such as seeking cost-effective alternatives, are the concerns of the pharmacist. For example, the choice of exchanging a high-priced branded antibiotic with a lower priced alternative should be at the discretion of a pharmacist. A pharmacist would provide cost-effective alternatives that have equivalent effectiveness with its brand substitute.
The pharmacist should always provide ample knowledge on medications to patients before they leave the pharmacy. Necessary information includes:
Dosage regimen
Indication
Side-effects
Route of administration
Mode of storage
A pharmacist can equally can carry out services to help check for vital signs to monitor chronic conditions such as diabetes, high blood pressure or hyperlipidaemia.
Confidentiality and accessibility
The pharmacist must always engage patients in a well-equipped consulting room. This is especially necessary in community practice and makes the patient more comfortable to explain private health issues for the pharmacist’s intervention. There must also be patient-pharmacist confidentiality that enables the patient give private information without the fear of being embarrassed or exposed to the public.
A pharmacist must be easily accessible. In cases where too many drugs (more than five prescription drugs) are taken at once by the patient (polypharmacy), the pharmacist can help to carry out medicine use review. This will help the patient escape the risks of drug interaction, adverse drug reactions and improve compliance.
Access to pharmacists has become easier through the introduction of the CareHub App – an online platform, with pharmacists available to answer patients’ entire drug-related concerns on the go. All the patient needs is to simply download the app, register and ask his or her questions. They will be immediately attended to by a professional. Talk about having your pharmacist at your fingertips!
By Pharm. Ayodeji Oni
(Freelancing for Advantage Health Africa)
Professor Bernice Oluwakemi Adegbehingbe is the Medical Director, Victory Life Specialist Hospitals, a conglomerate of multi-specialty health facilities, in Ile-Ife, Osun State. An indigene of Owo in Ondo State, Adegbehingbe graduated from Obafemi Awolowo University, Ile-Ife, where she bagged her Bachelor of Science (Honours) in Health Sciences in 1985, and her Bachelor of Medicine and Bachelor of Surgery (MBChB) in 1988.
The erudite scholar further obtained a Diploma in Ophthalmology from the Royal College of Surgeons in Ireland and a Masters in Advanced Ophthalmology from the University of Bristol.

A seasoned ophthalmologist and researcher, Adegbehingbe has published over 60 articles in reputable peer-reviewed international journals, as well as successfully mentoring more than 20 postgraduate doctors, some of whom are already in professorial cadres in their various universities.
In collaboration with fellow researchers across the country, Adegbehingbe has made very remarkable breakthroughs in the provision of more readily available and affordable therapeutic agent from a local plant – Garcinia kola (bitter kola). This anti-glaucoma medication has continued to enjoy increasing patronage throughout the country.
The Professor of Ophthalmology has also impacted the academic community tremendously. She served as the liaison officer (South Western Zone) for the Prevention of Blindness Programme, and coordinator of Prevention of Blindness Programme at Obafemi Awolowo University, Ile-Ife between 2009 and 2016.
As a further demonstration of her commitment to the provision of affordable healthcare to the average Nigerian, during her tenure as the dean of the Faculty of Clinical Sciences, Obafemi Awolowo University, she led eminent professors, senior academic staff and other medical specialists to conduct comprehensive free medical screening for over 5000 people across 14 local government areas in Osun State.
Prof. Adegbehingbe is a Fellow of both the West African College of Surgeons and National Postgraduate Medical College of Nigeria. She is currently an examiner in the postgraduate examinatins of these two colleges.
Adegbehingbe is also a Fellow of the International Council of Ophthalmology and International College of Surgeons. She is a member of American Academy of Ophthalmology; Oxford Ophthalmologic Congress, UK; and Middle East African Congress of Ophthalmology.
The renowned scholar has won many research grants and fellowships both nationally and internationally. She is a reviewer for many of the international peer-reviewed journals.
Prof. Adegbehingbe is happily married to a successful orthopaedic surgeon and blessed with children.
The announcement last month that the Global Alliance for Vaccine Initiative (GAVI) has extended its funding support for immunisation in Nigeria until 2028 is, no doubt, a cheering piece of news for the nation.This extension must however only be seen as a great opportunity for the country to finally and properly commence its journey to vaccine security for its teeming population.
The Minister of Health, Prof. Isaac Adewole, who broke the news, revealed that the board of GAVI, the largest global coalition of public and private sectors facilitating accelerated access to vaccines to children living in the world’s poorest countries, had extended the transitional period of vaccine support for Nigeria from 2021 to 2028, at a whopping cost of about 1.03 billion dollars.

The extension had followed a plea by the Nigerian government to GAVI for a reconsideration of an earlier 2001 agreement with GAVI, through which the global body had agreed to strengthen immunisation system in Nigeria by supporting the country with the introduction of life-saving vaccines such as Pneumococcal Conjugate Vaccine (PCV), Inactivated Polio Vaccine (IPV) and Pentavalent vaccines, as well as additional support for non-vaccine operations, at a cost of $732,130,326.
This agreement was supposed to end by 2021 but the Nigerian government had appealed to GAVI for an extension, stating that the nation was not ready to bear the financial burden of its immunisation programme. Unsurprisingly, while Nigeria awaited GAVI’s response to its plea, stakeholders in the health sector had been worried about the fate of the various immunisation initiatives in Nigeria after 2021. It was obvious that the nation was clearly incapable of meeting the vaccine needs of its people. There were no funds to buy vaccines for the citizens and no capacity to produce vaccines locally.
It must be noted that given the dicey gridlock in which the country found itself, the federal government’s decision to proactively request GAVI’s continued support, three years ahead of the 2021 deadline, was a judicious one. Yet, the government needs to realise that vaccine provision for its people is no longer just a health issue but a serious security concern. For the Nigerian nation with its huge population of almost 200 million to depend on external sources for over 80 per cent of its vaccine needs is not just inexcusable but utterly precarious. As the outbreaks of some serious vaccine-preventable conditions in recent times have shown, it is a great indiscretion for any nation – not especially one with vast resources as Nigeria – to be at the mercy of others for its drug or vaccine needs.
It is time Nigeria stopped this beggarly attitude. The federal government must make the most of the GAVI extension period by paying more serious attention to the critical issue of vaccine funding, as well as expediting the process of private-public-partnership and local vaccine production.
The recent inauguration of the board of a private local vaccine company, Biovaccines Nigeria Limited, by the present government, is a step in the right direction towards local vaccine production. However, the government must go beyond inauguration to actually coming up with further initiatives that will consolidate this move towards vaccine security by granting Biovaccines tariff waivers on raw materials and machineries for production. This must be backed by other necessary forms of support to the company.
It must be equally emphasised that government’s support for vaccine production must not be limited to Biovaccines. Rather it should begin to encourage and support other companies or organisations desirous of going into vaccine production. It is our view that the nation must be able to produce, at least, 70 per cent of its vaccine needs. Therefore, the more capable players who are willing to go this direction, the better it will be for the Nigerian nation.
Lastly, while Nigeria must act in tandem with international best practice, there must also be a concerted and well-articulated strategy to develop capacity for local research that will enhance local content sourcing of materials needed for our vaccine production. We must ensure that the vaccines that will be produced locally are ones that the processes of producing are well thought out and sustainable. The time to start is now.
From the earliest of times, there has always been a special class of women who defy all odds to achieve the incredible. In the history of healthcare research and delivery, some names readily come to mind in this regard. There was Elizabeth Blackwell, who was the first woman to obtain a medical degree; there was Florence Nightingale, who revolutionised nursing practice; there was Prof. Dora Akunyili, who rescued the Nigerian pharmaceutical sector from the grip of drug counterfeiters. There was Dr Ameyoh Adadevoh, who, at the risk of her life, formed a bulwark against the spread of Ebola in the country.

And, then, there is Professor (Mrs) Chinedum Peace Babalola (nee Anyabuike). Call her “the woman of the firsts”, scholar extraordinaire or highflying innovator and you would not be wrong in any way – because she is all of these and more. Having become a registered pharmacist in 1984, Babalola is one of the first few women to become a professor of pharmacy in Nigeria. Indeed, she was the first female professor of pharmacy at the University of Ibadan. She was the first female dean of the Faculty of Pharmacy, University of Ibadan. She was the first female pharmacist inducted as Fellow, Nigerian Academy of Science – the highest scientific award in Nigeria. She was the first female Nigerian inducted as Fellow, African Academy of Sciences. And she is currently the vice chancellor of Chrisland University, Abeokuta, Ogun State – the first female pharmacist to attain such position in Nigeria.
Pathway to excellence
Born into the family of Sir Dr Isaac Ebere and late Lady Adeline Anyabuike who hailed from Imo State, Prof. Babalola obtained her Bachelor of Pharmacy degree in 1983, her M.Sc. in 1987 and a PhD in Pharmaceutical Chemistry (Pharmacokinetics option) in 1997 from the University of Ife (now Obafemi Awolowo University, OAU). Therefater, she proceeded to the University of British Columbia, Vancouver, Canada for a pre-doctoral fellowship between 1994 and 1995. In 2012, she completed her postgraduate diploma in Advanced Industrial Pharmacy Training (IPAT) jointly from Kilimanjaro School of Pharmacy, Tanzania and Purdue University, USA.
She began her lecturing and research career as a junior trainee fellow, Department of Pharmaceutical Chemistry in 1985 at OAU. She joined the University of Ibadan in 1998, as a senior lecturer, a year after she received her PhD from OAU. In 2003, Babalola became an associate professor, after which she was promoted to full professor in 2006. She served as the head of department of Pharmaceutical Chemistry and director of General Studies Programme where she introduced a new course module – Drugs and Mankind – for all the undergraduate students of Pharmacy.
Not only did she introduce a course component, but she was known as an agent of change. Her innovative acumen propelled her to introduce a number of initiatives, including the malpractice-free processing of examination which the school adopted as post-UTME screening process till date.
Further strides
In 2015, UCH Ibadan appointed Babalola as a specialist/consultant, making her the first pharmacist to be so appointed by any tertiary hospital in Nigeria alongside being an adjunct professor at the College of Medicine, UI. Serving two terms as the seventh dean of Faculty of Pharmacy between 2013 and 2017, Babalola achieved two main agendas, among others. These were the undergraduate curriculum review and the building of a sophisticated laboratory complex for the Faculty.
Babalola’s research interest focuses majorly on pharmacokinetics/pharmacodynamics, pharmaceutical analysis, pharmacogenetics and bioethics as tools for studying drug disposition in Nigerians, in order to guide therapeutic optimisation in Africans. Her research has revealed significant drug-drug interactions between antimalarials and antibiotics, with significant reduction in antibiotic levels, which calls for dose adjustment. She and co-authors reported the first pharmacogenetic study in Nigerians (healthy and sickle cell patients). She co-conducted one of the largest pharmacogenetic/pharmacovigilance studies on sulpha drugs in over 1,000 healthy and HIV/AIDS infected Nigerians.
In 2011, Babalola led a multinational/interdisciplinary team, which won the MacArthur Foundation grant (approx. $1 million) to set up Centre for Drug Discovery, Development and Production (CDDDP), UI – first of its kind in Africa – for building the capacity of Africans to make their own medicines, as well as improving access to quality medicines.
Babalola was the principal investigator of the CDDDP; and so it came as no surprise when the Centre was chosen by NEPAD/AMRH as one the 11 centres of excellence in Africa and a number of its medicinal/herbal products ready for NAFDAC registration. In her pursuit to see significant improvement in the Nigerian healthcare system, she developed a novel High-Performance Liquid Chromatography, a technique in analytical chemistry that is used for separating, quantifying, and identifying components in a mixture. This method, used in the analysis of quinine in biometrics, has brought about clarification in the pharmacokinetics of quinine in Africa as well as forming the basis of malaria patent dose optimisation.
Her persistence and unrelenting desire to contribute to humanity and science through her research, alongside Dr Adeboye Adejare of the University of the Sciences in Pennsylvania, propelled her selection for the African Diaspora Initiative in 2014. She currently consults for pharmaceutical industries in the areas of drug quality assessment, bioequivalence and clinical trials.
Honours and recognitions
Babalola is a recipient of over 25 fellowships, awards, and grants across the globe. In 2016, she was selected as one of 10 most influential female scientists in Nigeria. She was also selected as the only African member, Strategy Working Group (SWG), joint Committee of International Council for Science (ICSU) and International Social Science Council (ISSC) in France.
Just recently (2018) she was named by Silverbird TV as one of the 16 prominent Nigerian women that have excelled in Science and Research. She also received a merit award from the Association of Lady Pharmacists (ALPS) of Nigeria due to her achievements and contributions to the pharmacy profession. She has over 100 publications (peer-reviewed and abstracts) in reputable journals. She has taught and mentored many students and has supervised over 50 Masters and PhD projects.
Babalola is married to Venerable Collins Olufemi Babalola of Ibadan Anglican Diocese.
Corn (Zea mays, Fam: Poaceae), called maize in Spanish, agbado in Yoruba, oka in Igbo and masara in Hausa, has been a staple crop in South, Central and North America for thousands of years. It is a seasonal crop in Nigeria. Being one of the most popular cereals in the world, it can be consumed in many different forms. Although corn is of many species, the most popular type in Nigeria remains the yellow and white corn. Other colours of corn are purple, red and black.
Constituents
Corn contains high amounts of insoluble fibre; carbohydrates, in form of starch and sugars; vitamins B1, B2, B3, B5, B6, B12, C, E and folic acid. Minerals found in corn include iron, magnesium, phosphorus, zinc, selenium and potassium.

Yellow corn is also a good source of two antioxidants, zeaxanthin and lutein, which are good for eye health. The nutrients may vary in composition and contents, depending on the species of corn. Generally, corn has amazing nutritional benefits. Also, these nutrients can be altered during the processing of maize into other different products.
Preparations
Corn, being popular as a food item, is enjoyed by people in various forms like whole corn, corn flour, cornstarch, corn gluten, corn syrup, cornmeal, corn oil, popcorn, cornflakes, etc. The grains can be cooked, roasted, fried, ground, pounded or crushed to prepare various food items like pap, tuwo, gwate, donkunu and a host of others. All these food types are readily available in various parts of Nigeria among different ethnic groups, notably the Yorubas, Hausas, Ibos, Ibiras, Ishas, Binis, Efiks, Yalas etc.
Uses
Globally, many people rely on corn as a primary source of nutrition. Corn is also used as livestock fodder. Apart from food, corn is also used as an additive, medicine and as raw material for industries.
Corn is processed to make an assortment of products, ranging from high fructose corn syrup to biofuels, all of which play important roles in human society.
Pharmacological actions
Besides helping with weight loss, the insoluble fibre in corn feeds good bacteria in your gut, which aids in digestion and helps give you regular bowel movements. This helps to reduce the risk of haemorrhoids and colorectal cancer.
Clinical studies in Japan have shown that purple corn could be a great ally in the fight against diabetes and obesity; a purple corn extract increases the activity of a gene that regulates the function of fat cells.
Studies have shown that yellow corn is rich in the carotenoid lutein which has antioxidant properties that can lower the risk of age-related vision loss, as well as preventing the cognitive decline which leads to Alzheimer’s disease.
Corn is a rich source of a phenolic compound and ferulic acid, an anti-cancer agent which has been shown to be effective in fighting tumours in breast cancer and liver cancer.
It has been widely reported that various species of corn contain compounds that prevent anaemia and constipation, promote good skin and eye care, delay aging process, help to manage noninsulin dependent diabetes, protect against hypertension and help in combating cancer.
Adverse effects
Allergy, increased blood sugar, bloating, indigestion, intestinal irritation, diarrhoea, tooth decay, osteoporosis, weight gain and lethargy have been associated with eating corn in excess.
Conclusion
Corn has great food, nutritional, medicinal, industrial and economic values. In spite of some adverse effects noted, corn, if consumed in moderation, will do more good than harm.
Do you know that just like your fingers, your tongue has its own unique print, which is different from anyone else’s in the world? DNA profiling has revealed that there is one individual in a trillion people. Studies have shown that all human beings are unique.
Be yourself and stop copying and competing with others. However, no matter how hard you try to change your personality, you can’t. A sound Congolese adage says, “Wood may remain ten years in the water, but it will never become a crocodile.”

You are the only person in the whole world that has your distinct attributes. So, you should stand out and not blend in. A copycat adapts himself to the world while an original adapts the world to himself. Be thyself.
Originality is derived from the root word original. The word original itself has its ancestry from the Latin word ořigō meaning to arise or be born. Originality is the quality of being new and interesting in a way that is different from anything that has existed before. Personally, I define originality as origin plus acceptability. This implies accepting your social and family background.
Your origin is your ancestry, your foundation, your source and where you sprang forth from. God has launched you where you are; it is your personal responsibility to launch yourself and your heritage to the world.
In construction, the higher a building will be, the deeper the foundation. In agriculture, the deeper the root, the huger the tree is. This truism signifies that the more you know about your personality, the better you can take the optimum advantage of your one shot at life.
The creator of man has fashioned him and placed him where He wants him to be. We had no power to determine the family we were born into, we just found ourselves in that family and it is left for us to accept it and be proud of the family or act otherwise.
A myriad of people are not contented with the family they automatically found themselves in. They wish it should have been a better family than what they see in terms of wealth, power, influence and other values. They are disturbed so much about this issue that, if possible, they would have changed their family, but it is not.
Sometimes, life could be quite unfair. Right from infancy, life throws challenges at us! Some have both parents, while others have lost one or both quite early in life. Some have a humble background while some have it all rosy. We really do not have choices where life places us.
This is the more reason we must endeavour to wise up to life early and accept our origin, in order to be able to remain on top of situations. The earlier, the better – if not in our teenage years, then in our early adulthood. We must challenge life equally by accepting who we are, our family background and deciding to make it better than the way we met it. Thus, the future of our lives and our families is in our hands; we can make it better not only for ourselves but also for our unborn generations.
A number of people spend their entire lives trying to change the way they were fashioned. American poet E.E. Cummings said, “To be nobody but yourself, in a world which is doing its best, day and night, to make you everybody else ‒ means to fight the hardest battle which any human being can fight and never stop fighting.” The greatest tragedy that can strike an individual is to fail to accept his origin and not be original.
The curious paradox is that when you are authentic, you can never be a shadow. All good things, which exist, are the fruit of originality. Note that the original remains intact after the photocopy might have become faded.
It will do you much good, if you absolutely accept where God fixed you in life and work diligently to make the optimum use of the position. Then, your story can be an inspiration to others beyond our generation.
You are number one. No one else in this world can be you, because you are unique, special and one in a lifetime. You are invaluable, inestimable, important, significant and useful to the world. Be original. Be yourself.
ACTION PLAN: Introduce yourself by yourself to yourself. Accept who you are. Be proud of who you are. Believe in yourself. Celebrate your uniqueness.
AFFIRMATION: I am unique, special and one in a lifetime. I am blessed and highly favoured.
I had a friend named Clifford some years ago and I enjoyed his company because he was good at telling stories. On one occasion, he told me that he was the best in his class in the secondary school and actually had alphas in the West African School Certificate exams in the seventies. He was so good in arts and science subjects that he found it difficult to decide what to study in the university.
Eventually, he entered the University of Ife (now Obafemi Awolowo University) Ile-Ife to study Mechanical Engineering. After the second year, he felt he had made a wrong choice of course. With his excellent scores in the arts subjects, he was able to migrate to the Faculty of Arts and led his class in the BA (English, Special Honours). He made Second Class Honours (Upper Division).

With his sound academic qualification, he was quickly offered employment by Shell, in the Personnel Department. According to him, there was nothing he lacked in Shell. He was given a very good salary with allowances, as well as a house and a car. After working for Shell for a few years, he resigned and got into the West African Examination Council (WAEC) to have time for further studies, according to him.
While at WAEC, he registered for MBA at the University of Lagos. The course opened his eyes to opportunities in business. Thereafter, he resigned from WAEC and established the business of buying and selling books at Yaba. We actually met for the first time when I sauntered into that bookshop to look for a book written by John Maxwell. When I realised that he passed through the “Great Ife”, my alma mater, we became friends immediately and he told me nearly everything about his life.
The next time I went there to pick up another book, someone else emerged as the owner and told me that Clifford had handed over the business to him. I was surprised and just phoned him immediately to know what had happened. He informed me that everything was all right but he had discovered his love for computers. He said he had secured a place at the Computer Village, Ikeja, and the business was exciting and profitable. He regretted spending some years at Ife and even working for Shell and WAEC. According to him, he should have studied Computer Engineering in the University and gone into computer business a long time ago.
Clifford is one of those people who are blessed with many abilities. They have the intelligence and capability to do many things and believe they can do everything. But the truth is that nobody was born to do everything. Nobody was created to solve all human problems.
Just think of some people who have become famous and you will realise that they focused on a specific area of service to humanity. Focusing and concentrating on a specific area makes you an expert or specialist. Think of people like Marie Curie, Chinua Achebe, Dr Myles Munroe, Steve Jobs, Bill Gates, Mark Zuckerberg and so on. These people concentrated on one or two gift areas to become successful. Even if you are multi-talented, you have to decide which talents to stir up to serve humanity.
God gives talents to people in different measures. Some people may have many talents and therefore capable of doing many things. When these gifts are not well managed, it can cause such people to be ineffective. In the attempt to use all their gifts, they fail to develop any of them to become successful. For such people, there is need to focus on specific gifts and develop them.
No one was created to be a “jack-of-all-trades and master of none”. Some gifts can cause distraction from your vision and you end up not excelling in any area. It is nearly impossible to distinguish yourself in many fields at the same time. However, some geniuses have tried to do so to a limited extent. You must decide to concentrate on related gifts to make an impact on society.
One of my friends used to quote from Philippians 4:13 which says, “I can do all things through Christ who strengthens me”. But I always retort, “Yes, all things which Christ has asked you to do.” Those things God created you to do, He will surely give you the enablement and provide the resources to achieve them in order to fulfill the purpose of your creation. But for those things you took upon yourself to do, you are on your own.
Since Satoshi Nakamoto (pseudonym) first published a paper titled “Bitcoin: A Peer-to-Peer Electronic Cash System” in 2008, the blockchain technology behind his concept has continued to gain reputation and acceptance. Bitcoin is the first and most controversial application of blockchain which has generated multibillion-dollar worth of anonymous transactions. Blockchain has been termed as “new internet” by many people and has, no doubt, been a tech buzz word for the past few years. Transparency and trust aptly describe the technology underlying the fabric of bitcoin. Blockchain technology is a consensus distributed ledger for digital transactions. In lay man’s terms, think of blockchain as a database that is shared and saved on several computers in which any addition or changes in the content of the stored information will require the verification and approval of everyone involved in the changes. This is explained by bitcoin’s three main design components which are: distributed network, shared ledger and digital transactions.
Wider application
Beyond financial transaction application of blockchain in bitcoin, the technology has some unique features and strengths that give credence to its application in diverse sectors such as agriculture, governance, legal system, voting system, land use/real estate, smart contracts, database and record management, and value chain.

Notable among these features are the fact that the technology is immutable, reliable, secured and transparent. Prior to the invention of blockchain, third parties, such as banks, were saddled with the responsibility of managing risks associated with financial transactions but through blockchain, these risks can be eliminated without a third party.
However, while the elimination third party is a unique selling point for blockchain, it is also the main source of controversy and resistance to adoption by government, policy makers and regulatory agencies.
Relevance to healthcare
The healthcare systems of developing countries have lots of gaps that translate to poor health indices and outcomes. The implication of these deficiencies on labour force and economy is huge and calls for pragmatic interventions.
Inefficiency and corruption in the sector can be better managed if a tested and proven technology, such as blockchain, can be applied to solve the healthcare-related challenges. For instance, blockchain technology is being currently deployed to solve Electronic Medical Records (EMR) challenges. At the moment, many health institutions do not have updated digital health records of their patients and where the records exist, they do in isolation. This implies that the medical records of a patient in University College Hospital in Ibadan, for instance, is not accessible, real time, to the patient or healthcare providers in Ahmadu Bello University Teaching Hospital in Zaria, should the patient travel there and require healthcare services.
Having EMR on a blockchain backend can ensure data integrity and security. Since the information is not stored ne a single computer in a single location, it is practically not feasible to alter records or lose records due to deliberate sabotage or disasters such as fire outbreak.
Assurance of quality medical records will, no doubt, reduce preventable deaths in accidents and emergencies, and improve the management of communicable and non-communicable diseases.
Supply chain management of medicines, medical equipment and allied products is another viable application of blockchain technology in healthcare system. The issue of counterfeit and substandard drugs in Nigeria has been a source of concern for health policy actors because of its huge implications on health outcomes. The strengths of blockchain technology in terms of immutability, distributed ledger and reliability are the exact antidotes to the weaknesses of the supply chain of medicines in Nigeria.
At the moment, the country still largely depends on imported medicines, distributed through an unfortunate and chaotic drug distribution system. Counterfeit medicines clandestinely get introduced to the supply chain of medicines and unsuspecting consumers purchase these medicines to their peril. With blockchain technology, pharmaceutical companies can create a niche for their brands by ensuring that their products’ details are logged into blockchain and their progression across the supply chain is made available to consumers in a user-friendly manner. With this, the demand side of counterfeit medicines will be blocked and immutable technology will replace unethical human practices that keep a few criminals wealthy at the expense of innocent citizens.
Applications of blockchain technology are evolving and the use in cases discussed above are at different stages of development, ranging from ideation to piloting to actual scale-up of technology development. There are also some questions about cost of building the technology and how it integrates with other existing infrastructure in country.
The Fourth in the series of lectures in honour of Pharm. (Mall.) Dahiru Suleiman Wali, popularly known as D.S Wali, is scheduled for Monday, 23 July 2018, in the main Auditorium of the Arewa House, Kaduna by 10:00 am.

It will be recalled that the first lecture was delivered by Professor Umar Usman Pateh, a member of the Book Project Committee, and the then Dean, Faculty of Pharmaceutical Sciences, ABU, Zaria, on the 80th birthday of Pharm. D.S Wali, on 23 July 2015.
Thereafter, the second and the third editions of the lectures were successfully held in Kaduna and were delivered by Professor Haruna Abdu Kaita, Pharmacist and Vice-Chancellor of Federal University, Dutsen-Ma, Katsina State, and Professor Magaji Garba, Pharmacist and Vice-Chancellor, Federal University, Gusau, Zamfara State, respectively.
The 2018 edition of the birthday anniversary lecture series would be delivered by Professor Ezzeldin Mukhtar Abdurahman with the title:-“The Role of Pharmacists in the Campaign Against Drug Abuse”.
Prof. Abdurahman, a pharmacist and academic was Vice-Chancellor continuously for ten years; first in Kaduna State University (KASU), Kaduna (2006 -2011) and Bauchi State University (BASU), Gadau, Bauchi State (2012-2016).
The chairman of the occasion will be Professor Abdullahi Mustspha, the immediate past Vice -Chancellor, Ahmadu Bello University (ABU) Zaria.
Chairman of the Book Project Committee, Prof. Ahmed Tijjani Mora, and members including Professor Ibrahim Adamu Yakasai; Pharm. Ahmed Gana Mohammed; Pharm Aliyu Jibrin, Secretary and other well wishers congratulate and rejoice with Mall. Wali on his 83rd birthday anniversary in advance.
By Prof. Ahmed Tijjani Mora.
As the world marked this year’s International Day against Drug Abuse and Illicit Trafficking, Nigerian youths, especially adolescence, have been urged to say no to drug abuse and addiction, due to its harmful effects to health.
The International Day against Drug Abuse and Illicit Trafficking is an effort of the United Nations aimed at strengthening action and spreading awareness about drug abuse and illegal drug trade in the world.

Making the call recently during the National Essay Competition for Secondary Schools, organised by the Association of Community Pharmacists of Nigeria (ACPN), Drug Information Centre (DIC) to commemorate this year International Day against Drug Abuse and Illicit Trafficking, which held at the Sickle Cell Centre, Idi-Araba, Lagos, the Director General of NAFDAC, Prof. Moji Adeyeye, noted that drug abuse is a major health problem globally, saying it is no longer a secret that many Nigeria youths, especially those in secondary schools experiment with drugs at one point or the other.
According to her, hard drugs cause a number of vices, including armed robbery, kidnapping, raping, prostitution, and even health challenges like madness, adding that there is also a high risk of liver and kidney diseases, including cancer, and other terminal illnesses, saying many of those engaged in such practices will not only have their lives’ dreams cut short, but also become less contributory to the society.

Also speaking at the event, the National Chairman, ACPN, Dr Albert Kelong Alkali, disclosed that drug abuse is one of the greatest challenges the country is facing presently, adding that there is no better time than now to start sensitising the younger ones about the dangers inherent in it, as it has become a big menace to the society.
Speaking further, Alkali noted that if the older generation refuse to rise up and assist the young ones today, so as to rid our society off the menace, it will come back to haunt them in the future. “These children are our future, so the earlier we start protecting their future, the better for our nation, because by the time we leave, they are the ones that will take over,” he said.
Speaking earlier, Pharm. Bukola Folorunsho, chairman, DIC, ACPN, explained that the International Day against Drug Abuse and Illicit Trafficking is an effort of the United Nations aimed at strengthening action and spreading awareness about drug abuse and illegal drug trade in the world, adding that it is an expression of determination towards the goal of achieving an international drug-free society.
According to her, the observance of International Day against Drug Abuse and Illicit Trafficking is very significant because there are varied socio-economic and cultural issues related to illegal drugs and drug trafficking, adding that drug abuse results in perhaps the worst kind of health problems and has become a major crime in almost all the country of the world.
Speaking on the theme for this year’s programme, “Listen First”, she disclosed that listening to children and youth is the first step to help them grow healthy and safe. “Given the increased incidence of drug abuse in the youth and kids, it is important to listen to them first. This initiative aims at increasing support for science-based prevention of drug use and invests more on the well-being of kids, youngsters and their families,” he advised.
According to her, parents and members of the society should not stop creating awareness among their children and youths respectively on the dangers of drug abuse, adding that parents should monitor their children closely if they must effectively tackle drug use in them.
The high point of the event was the presentation of cash prizes to the winners, however at the end of the keen contest, which involved essay writing and presentation, five students from four schools, emerged winners and they included, Hephzibah Ogbonaya, Living Word Academy Secondary, Aba, Abia State; Eniola Sanya of Reagan Memorial Baptist Girl Secondary School, Yaba, Lagos; Divine Nkala from Federal Science and Technology College, Lagos; Ebubechukwu Udeh, from Ikeja Senior High School; and Festus Erondu, from Living Word Academy Secondary School, Aba, Abia State.
Meanwhile, the first prize of Hundred Thousand Naira, was presented to Hephzibah Ogbonaya, Living Word Academy Secondary, Aba, Abia State, while Eniola Sanya of Reagan Memorial Baptist Girl Secondary School, Yaba, Lagos; Divine Nkala from Federal Science and Technology College, Lagos, were presented with prizes of Seventy Thousand Naira, and Fifty Thousand Naira, for coming second and third consecutively.
Other dignitaries at the event included, Pharm. Olufemi Ismail Adebayo, immediate past chairman, ACPN; Pharm. Abosede Idowu, national secretary, ACPN; Pharm. Lawrence Ekhator; Pharm. Madehin Gafar Olanrewaju; and Pharm. Sola Onanusi.
-As WHO Set to Tackle Prevalence in Affected Countries
The World Health Organisation (WHO) is set to commence the distribution of a paediatric chewable formulation of mebendazole to countries with high prevalence of helminths infection, known as intestinal worms infection.
The world’s apex health institution recently revealed that “more than 1.5 billion people, or 24% of the world’s population, are infected with soil-transmitted helminths worldwide. Infections are widely distributed in tropical and subtropical areas, with the greatest numbers occurring in sub-Saharan Africa, the Americas, China and East Asia”.

The WHO through a release noted that over 267 million preschool-age children live in areas where these parasitic worms are intensively transmitted and periodic treatment is required to prevent associated morbidity.
The statement further explained that the current practice of preventive treatment in endemic areas for the three main worm species, is in tandem with the 2017 updated published evidence-based guideline of WHO on regular large-scale treatment of population groups at risk of soil-transmitted helminth infections.
Mebendazole is one of the medicines recommended by WHO to treat intestinal worm infections of humans. This formulation was approved by the United States Food and Drug Administration in 2016 and is now donated to WHO by the pharmaceutical company Johnson & Johnson.
The document reads in part : “Now, young children aged 1 year or older children who have difficulty swallowing solid tablets will be able to easily ingest the tablet, which has a pleasant taste and can either be chewed or turned into a soft mass with a little water,” said Dr Antonio Montresor, who heads WHO’s programme on soil-transmitted helminthiasis.
“Initially, the quantity of this paediatric formulation will be limited, with full roll-out planned as production capability increases. Paediatric mebendazole will fill a major gap in the treatment of intestinal worms.
“The new formulation was developed in response to WHO’s call for a more child-friendly version. It overcomes a major difficulty in administering the medicine to children,” said Cori Vail, Director of Programme Strategy for Soil Transmitted Helminths at Johnson & Johnson.
Meanwhile, the pharmaceutical company Johnson & Johnson has recognised that preschool children are an important group at risk for intestinal worms, and have decided to include the new formulation in their current donation programme through WHO, with plans to gradually increase production.
In line with Johnson & Johnson’s magnanimity to make the medicine available to affected countries, the WHO has sent invites to countries that are facing difficulties in procuring deworming (anthelminthic) medicines and are planning to conduct large-scale treatment campaigns for preschool children in 2019 to submit their requests for paediatric mebendazole to the WHO Department of Control of Neglected Tropical Diseases before 31 August 2018.